Predicting long-term disease control in transplant-ineligible patients with multiple myeloma: impact of an MGUS-like signature

Disease control at 5 years would be a desirable endpoint for elderly multiple myeloma (MM) patients, but biomarkers predicting this are not defined. Therefore, to gain further insights in this endpoint, a population of 498 newly diagnosed transplant-ineligible patients enrolled in two Spanish trials...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Otero, Paula, Mateos, María Victoria, Martínez-López, Joaquín, Hernández, Miguel-Teodoro, Ocio, Enrique M., Rosiñol, Laura, Martínez, Rafael, Teruel, Ana-Isabel, Gutiérrez, Norma C., Bargay, Joan, Bengoechea, Enrique, González, Yolanda, de Oteyza, Jaime Pérez, Gironella, Mercedes, Nuñez-Córdoba, Jorge M., Encinas, Cristina, Martín, Jesús, Cabrera, Carmen, Palomera, Luis, de Arriba, Felipe, Cedena, María Teresa, Puig, Noemí, Oriol, Albert, Paiva, Bruno, Bladé, Joan, Lahuerta, Juan José, San Miguel, Jesús F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423121/
https://www.ncbi.nlm.nih.gov/pubmed/30886139
http://dx.doi.org/10.1038/s41408-019-0176-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423121/
https://www.ncbi.nlm.nih.gov/pubmed/30886139
http://dx.doi.org/10.1038/s41408-019-0176-x

Ejemplares similares